Unmethylated Glioblastoma

Oncology
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Vaccine
1100%

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Papivax
PapivaxTaiwan - Taipei
1 program
1
Personalized Neoantigen DNA vaccinePhase 1Vaccine1 trial
Active Trials
NCT05743595Active Not Recruiting27Est. Mar 2029

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
2027
2028
2029
PapivaxPersonalized Neoantigen DNA vaccine

Clinical Trials (1)

Total enrollment: 27 patients across 1 trials

NCT05743595PapivaxPersonalized Neoantigen DNA vaccine

Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma

Start: Oct 2023Est. completion: Mar 202927 patients
Phase 1Active Not Recruiting

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
23m ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
23m ago

Office Administrator

SystImmune
23m ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
34m ago

Working Student Office Management Support (m/f/d)

Mindpeak
Hamburg
37m ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
37m ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)